tiprankstipranks
Trending News
More News >
Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market

Bone Biologics (BBLG) Financial Statements

Compare
71 Followers

Bone Biologics Financial Overview

Bone Biologics's market cap is currently $2.31M. The company's EPS TTM is $-4.865; its P/E ratio is ―; Bone Biologics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -4.22M$ -9.43M$ -3.67M$ -1.10M$ -825.01K
EBITDA$ -4.22M$ 479.57K$ 0.00$ 0.00$ -825.01K
Net Income$ -7.32M$ -8.95M$ 695.93K$ -1.61M$ -1.82M
Balance Sheet
Cash & Short-Term Investments$ 3.33M$ 3.03M$ 7.54M$ 6.68M$ 0.00
Total Assets$ 3.86M$ 3.74M$ 8.50M$ 6.68M$ 0.00
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 11.72M
Net Debt$ -3.33M$ -3.03M$ -7.54M$ -6.68M$ 11.72M
Total Liabilities$ 377.71K$ 831.40K$ 2.55M$ 99.91K$ 13.69M
Stockholders' Equity$ 3.48M$ 2.91M$ 5.95M$ 6.58M$ -13.69M
Cash Flow
Free Cash Flow$ -4.12M$ -9.56M$ -3.57M$ -1.23M$ -426.93K
Operating Cash Flow$ -4.12M$ -9.56M$ -3.57M$ -1.23M$ -426.93K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 4.42M$ 5.04M$ 4.43M$ 7.90M$ 402.79K
Currency in USD

Bone Biologics Earnings and Revenue History

Bone Biologics Debt to Assets

Bone Biologics Cash Flow

Bone Biologics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis